New Breakthrough in Bladder Cancer Treatment – Dr. Karine Tawagi скачать в хорошем качестве

New Breakthrough in Bladder Cancer Treatment – Dr. Karine Tawagi

In this segment, Dr. Karine Tawagi breaks down the latest FDA-approved treatment approach for muscle-invasive bladder cancer, spotlighting the Niagara study and its implications for patient care. With a growing focus on bladder preservation, she explains how new therapies like gemcitabine cisplatin durvalumab are offering hope to cisplatin eligible bladder cancer patients looking for better outcomes before and after surgery. What you’ll learn in this video: ▶ What the Niagara study means for the future of bladder cancer treatment ▶ How neoadjuvant therapy is being redefined with bladder cancer immunotherapy ▶ Why bladder preservation is gaining ground among patients avoiding bladder cancer surgery ▶ Key insights into bladder cancer symptoms, signs of bladder cancer, and early bladder cancer diagnosis ▶ The importance of recognizing bladder cancer risk factors and expanding awareness around bladder cancer treatment options This discussion is a timely look at how clinical research is opening up new paths for bladder cancer recovery and advancing the field of bladder cancer awareness. #bladdercancer #muscleinvasivebladdercancer #bladdercancertreatment #niagrastudy #cisplatineligible #bladdercancerimmunotherapy #bladdercancersurgery #bladderpreservation #bladdercancerrecovery #drkarinetawagi #mdnewsline